EX-23.1 6 kdny-ex231_8.htm EX-23.1 kdny-ex231_8.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-203508, 333-210016, 333-216373, 333-223382, 333-229915, 333-237034, 333-249351 and 333-255109) and the Registration Statement on Form S-3 (No. 333-255099) of Chinook Therapeutics, Inc. of our report dated March 17, 2022 relating to the financial statements, which appears in this Form 10-K.

 

 

/s/ PricewaterhouseCoopers LLP

Seattle, Washington

March 17, 2022

 

 

 

1